Van Lanschot Kempen Investment Management N.V. decreased its holdings in shares of Envista Holdings Corporation (NYSE:NVST – Free Report) by 50.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,011,327 shares of the company’s stock after selling 1,031,725 shares during the quarter. Van Lanschot Kempen Investment Management N.V. owned about 0.62% of Envista worth $21,956,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of NVST. Caitong International Asset Management Co. Ltd raised its stake in Envista by 16,711.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after purchasing an additional 1,504 shares in the last quarter. Allworth Financial LP raised its stake in shares of Envista by 75.4% in the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after acquiring an additional 776 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Envista by 73.1% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after acquiring an additional 949 shares during the period. IFP Advisors Inc raised its stake in shares of Envista by 102.9% in the fourth quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock valued at $46,000 after acquiring an additional 1,071 shares during the period. Finally, EverSource Wealth Advisors LLC raised its stake in shares of Envista by 378.0% in the second quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock valued at $47,000 after acquiring an additional 1,909 shares during the period.
Envista Trading Up 0.2%
NYSE NVST opened at $24.54 on Friday. The company’s 50-day moving average price is $25.02 and its 200-day moving average price is $24.71. The company has a current ratio of 2.44, a quick ratio of 2.06 and a debt-to-equity ratio of 0.47. The stock has a market cap of $3.99 billion, a PE ratio of 59.86, a PEG ratio of 1.39 and a beta of 0.88. Envista Holdings Corporation has a 12 month low of $18.25 and a 12 month high of $30.42.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on NVST shares. Evercore reissued an “outperform” rating and issued a $33.00 target price on shares of Envista in a research note on Thursday, May 7th. Zacks Research downgraded shares of Envista from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Wall Street Zen downgraded shares of Envista from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 9th. Barclays reduced their target price on shares of Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a research note on Thursday. Finally, Citigroup started coverage on shares of Envista in a research note on Wednesday, April 15th. They issued a “neutral” rating and a $29.00 target price on the stock. Six equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, Envista currently has an average rating of “Hold” and an average price target of $28.67.
Get Our Latest Stock Analysis on NVST
About Envista
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Featured Articles
- Five stocks we like better than Envista
- MarketBeat Week in Review – 06/08 – 06/12
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
